← Back to Search

Spermatic Cord is isolated from the mesh for Inguinal Hernia

N/A
Waitlist Available
Led By John A Morrison, MD;FRCS(C)
Research Sponsored by Chatham Kent Health Alliance
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Clinical diagnosis of a primary unilateral inguinal hernia
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year postoperatively
Awards & highlights
No Placebo-Only Group

Summary

There are in excess of 1 million operations performed annually to repair inguinal hernias, mostly in the male population. Unfortunately, some patients continue to suffer both groin or testicular pain for varying lengths of time postoperatively. This can lead to a severe degradation of the patient's lifestyle, work habits and sexual function. The origin of the pain is felt to be secondary to the inflammatory reaction caused by the mesh. This also involves the spermatic cord and its structures, leading to orchidinia and possibly azospermia.

Eligible Conditions
  • Inguinal Hernia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year postoperatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evaluation of groin or testicular pain lasting longer than 3 months postoperatively.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Spermatic Cord is isolated from the meshExperimental Treatment1 Intervention
The inguinal ligament is interposed between the cord and the mesh and then repaired. This isolates the cord from the mesh and the splinting function of the overlying inguinal ligament.
Group II: Spermatic Cord in contact with meshActive Control1 Intervention
Where the spermatic cord has been allowed to remain in contact with the mesh.

Find a Location

Who is running the clinical trial?

Chatham Kent Health AllianceLead Sponsor
John A Morrison, MD;FRCS(C)Principal InvestigatorChatham Kent Health Alliance
~15 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top